Repositive

Participants in the round included both new and existing investors.

The resource will offer easy access to an inventory of vendors with patient-derived xenograph models as well as associated molecular data for oncology drug discovery projects.

Repositive's platform, which is currently in beta testing, will include information from Xpressomics' data repositories.

The company will use the funds to further develop software for sharing genomic data, and to initiate research collaborations.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.